Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Aksept- og forpliktelsesterapi for religiøs OCD

25. september 2026 oppdatert av: David Johnson, University of Alabama at Birmingham

Effekten av aksept- og forpliktelsesterapi på religiøst orientert tvangslidelse

The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

10

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

  • Navn: Nicholas Borgogna, PhD
  • Telefonnummer: 7579693677
  • E-post: borgogna@uab.edu

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35233
        • Rekruttering
        • University of Alabama at Birmingham
        • Ta kontakt med:
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • 18 years old
  • Meet cutoff scores for scrupulosity

Exclusion Criteria:

  • Presence of psychotic symptoms within six months of screening
  • Current suicidal/homicidal plan/intent and/or a suicide/homicide attempt within 6 months of screening
  • Non-suicidal self-injury within 6 months of screening
  • Narcotics use within 3 months of screening
  • Purging/restricting behavior within 3 months of screening.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Acceptance and Commitment Therapy

Participants will receive twelve consecutive weeks of acceptance and commitment therapy

participants will then receive ACT-based individual therapy weekly for twelve weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Scrupulosity Obsessions and Compulsions Scale
Tidsramme: At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)

The Scrupulosity Obsessions and Compulsions Scale (SOCS) is a 10-item scale that asks participants how often they experience religious OCD obsessions and compulsions. The questions are asked on a scale ranging from 0 (Very Rarely) to 5 (Very Often).

At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
Experiential Avoidance Rating Scale
Tidsramme: At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)

The Experiential Avoidance Rating Scale (EARS) is a 6-item scale that asks participants how true statements about avoiding experiences are for them. The questions are asked on a scale ranging from 1 (Never True) to 5 (Very Often True).

At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Centrality of Religiosity Scale - Interreligious 20
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Centrality of Religiosity Scale - Interreligious 20 (CRSi-20) is a 20-item scale assessing religiosity across 5 dimensions (Intellect, Ideology, Public practice, Private practice, Experience). The questions are asked on scales ranging from Never to Several times a day, Never to Very often, and Not at all to Very much so.

Pre and post intervention which in general lasts 12 weeks
Yale-Brown Obsessive and Compulsive Scale - Self Report
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Yale-Brown Obsessive and Compulsive Scale (Y-BOCS) is a 12-item scale that asks participants whether they experience various OCD obsessions and compulsions. Participants are then asked how much time is spent on these obsessions and compulsions, whether they give in to the urge to perform compulsions, how strong the drive is to give in to compulsions, how they would feel if they were prevented from engaging in compulsions, and how much the compulsions and avoidance of compulsions interfere with their functioning.

Pre and post intervention which in general lasts 12 weeks
Patient Health Questionnaire - 9
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Patient Health Questionnaire (PHQ-9) is a 9-item scale that asks participants how often they have been bothered by aspects of depressive symptoms. The questions are asked on a scale ranging from 0 (Not at all) to 5 (Nearly every day).

Pre and post intervention which in general lasts 12 weeks
Generalized Anxiety Disorder - 7
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Generalized Anxiety Disorder Scale (GAD-7) is a 7-item scale that asks participants how often they have been bothered by statements capturing aspects of anxiety. The questions are asked on a scale ranging from 0 (Not at all) to 3 (Nearly every day).

Pre and post intervention which in general lasts 12 weeks
The Intrinsic Spirituality Scale
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Intrinsic Spirituality Scale is a 6-item scale that asks participants about aspects of their spirituality.

Pre and post intervention which in general lasts 12 weeks
Psy-Flex
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Psyflex questionnaire is a 6-item scale that measures aspects of psychological flexibility. The questions are asked on a scale ranging from very seldom to often.

Pre and post intervention which in general lasts 12 weeks
Almost Perfect Scale - Revised
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Almost Perfect Scale - Revised is a 23-item scale that asks participants their agreement on items capturing perfectionism. The questions are asked on a scale ranging from 1 (Strongly disagree) to 7 (Strongly agree).

Pre and post intervention which in general lasts 12 weeks
The Alcohol Use Disorders Identification Test
Tidsramme: Pre and post intervention which in general lasts 12 weeks

The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item scale that asks participants about their alcohol consumption.

Pre and post intervention which in general lasts 12 weeks
National Institute on Drug Abuse Screener
Tidsramme: Pre and post intervention which in general lasts 12 weeks

National Institute on Drug Abuse Screener (NIDA) is a 1-item scale that asks participants how often they use a variety of substances. The questions are asked on a scale ranging from Never to Daily or Almost Daily.

Pre and post intervention which in general lasts 12 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. juli 2025

Primær fullføring (Antatt)

1. mars 2027

Studiet fullført (Antatt)

1. mars 2027

Datoer for studieregistrering

Først innsendt

16. oktober 2024

Først innsendt som oppfylte QC-kriteriene

16. oktober 2024

Først lagt ut (Faktiske)

18. oktober 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

25. september 2026

Sist bekreftet

1. mars 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IRB-300013565-001
  • UAB (Annen identifikator: UAB)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .